Evidence map›Paper›PMID 25335492›Full record

ArticleEuropean journal of human genetics : EJHG2015

Clinical utility gene card for: Abetalipoproteinaemia--Update 2014.

John R Burnett, Damon A Bell, Amanda J Hooper, Robert A Hegele

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Current Diagnosis and Management of Familial Hypobetalipoproteinemia 1.Journal of atherosclerosis and thrombosis · 2024
    Review
  3. Article
  4. Current Diagnosis and Management of Abetalipoproteinemia.Journal of atherosclerosis and thrombosis · 2021
    Review
  5. A Novel Variant inJACC. Case reports · 2020
    Article
  6. Article
  7. Abetalipoproteinemia Due to a Novel Splicing Variant inJournal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John R Burnett1] Department of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, Western Australia, Australia [2] School of Medicine & Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
Damon A Bell1] Department of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, Western Australia, Australia [2] School of Medicine & Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
Amanda J Hooper1] Department of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, Western Australia, Australia [2] School of Medicine & Pharmacology, University of Western Australia, Perth, Western Australia, Australia [3] School of Pathology & Laboratory Medicine, University of Western Australia, Perth, Western Australia, Australia.
Robert A HegeleRobarts Research Institute, London, Ontario, Canada.

Funding

Canadian Institutes of Health Research MOP-13430Canadian Institutes of Health Research MOP-79533
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AbetalipoproteinemiaCarrier ProteinsFemaleHumansMaleCarrier Proteinsmicrosomal triglyceride transfer protein

Identifiers

PMID25335492
PMCPMC4795071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.